Metallothionein-1G (MT-1G), a member of the MT family, was recently identified as a negative regulator of ferroptosis and a positive regulator of sorafenib resistance in HCC and could be used as a biomarker to explore the impact of Sorafenib on redox metabolism of cancer cells. Here, MCAT is linked to hepatocellular carcinoma.